Globe Life (GL) Q3 2025 10-Q Quarterly Report
Globe Life (GL) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Globe Life Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $3.6B for nine months ended Sept 30, 2025, up 5% YoY from $3.44B; life premium $2.51B up 3%, health premium $1.1B up 8%
- • Net operating income $925M, up 10% YoY; life underwriting margin 46% of premium vs 42% YoY, health underwriting margin 26% vs 27% YoY
- • Best segment: Life insurance underwriting margin $1.16B, +14% YoY; worst: investment segment excess income $108M, down 15% YoY
- • Cash and short-term investments $366M at Sept 30, 2025, up from $250M at Dec 31, 2024; repurchased 4.2M shares at $124 average costing $515M
- • Management expects continued mid-teen operating ROE excluding AOCI; focus on agency growth and technology to support sales; cautious on investment yields and claims trends
Risk Factors
- • Section 'risk_factors' was empty or not found.
Globe Life Q3 2025 Quarterly FinancialsXBRL
Revenue
$1.5B
▲ +4.0% YoY▲ +2.1% QoQ
Net Income
$388M
▲ +28.0% YoY▲ +53.4% QoQ
Net Margin
25.6%
▲ +482bp YoY▲ +857bp QoQ
ROE
6.8%
Total Assets
$30.5B
EPS (Diluted)
$4.70
▲ +37.4% YoY▲ +53.6% QoQ
Operating Cash Flow
$306M
▼ -10.2% YoY▼ -0.6% QoQ
Source: XBRL data from Globe Life Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Globe Life
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.